文献速递产科母胎医学

低剂量阿司匹林与未产女性自发性早产减少相关

Low-dose aspirin is associated with reduced spontaneous preterm birth in nulliparous women.
PubMed 文献 · Am J Obstet Gynecol · 2018-06-18

本研究为随机安慰剂对照试验的二次分析,纳入2543例健康低风险未产单胎妊娠女性,比较13-25周起始60毫克阿司匹林与安慰剂。低剂量阿司匹林组自发性早产<34周率为1.03%,安慰剂组为2.34%(OR 0.43,95%CI 0.26-0.84),校正后aOR 0.46(95%CI 0.23-0.89);<37周自发性早产及总体早产率两组无显著差异。

要点

  • 低剂量阿司匹林组自发性早产<34周率1.03%,安慰剂组2.34%,OR 0.43(95%CI 0.26-0.84)。
  • 校正混杂因素后,低剂量阿司匹林组自发性早产<34周的aOR为0.46(95%CI 0.23-0.89)。
  • 自发性早产<37周及总体早产<37周、<34周率两组无显著差异。

核心结论

  • 低剂量阿司匹林与健康无合并症未产女性自发性早产<34周大幅减少相关,作者认为这提示一种需要进一步研究的早产预防新治疗选择。

研究设计与样本

  • 此为随机安慰剂对照低剂量阿司匹林预防子痫前期试验的二次分析,纳入健康低风险未产女性2543例,其中阿司匹林组1262例(49.6%)、安慰剂组1281例(50.4%)。
  • 干预为60毫克阿司匹林或匹配安慰剂,于孕13-25周起始。
  • 研究限于单胎、无畸形妊娠;既往仅允许有孕早期终止妊娠史,不允许有<20周自然流产史;本次妊娠<20周丢失或终止、产前死胎或随访数据缺失者排除。

主要发现

  • 自发性早产<34周率在低剂量阿司匹林组为1.03%(n=13),安慰剂组为2.34%(n=30),OR 0.43(95%CI 0.26-0.84)。
  • 自发性早产<37周率在低剂量阿司匹林组为6.58%(n=83),安慰剂组为7.03%(n=90),OR 0.97(95%CI 0.71-1.33)。
  • 总体早产<37周率在低剂量阿司匹林组为7.84%(n=99),安慰剂组为8.2%(n=105),OR 0.97(95%CI 0.72-1.31)。
  • 校正体质指数、种族、吸烟、婚姻状况和教育水平后,低剂量阿司匹林组自发性早产<34周的aOR为0.46(95%CI 0.23-0.89)。
  • 总体早产<34周、<37周及自发性早产<37周率在低剂量阿司匹林组与安慰剂组相似。

临床怎么用

  • 原文结论指出低剂量阿司匹林与健康无合并症未产女性自发性早产<34周大幅减少相关,并认为这些发现提示一种需要进一步研究的早产预防新治疗选择。

局限性

  • 原文结论指出这些发现提示一种需要进一步研究的早产预防新治疗选择。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Preterm birth is one of the leading causes of perinatal morbidity and mortality. Clinical data suggest that low-dose aspirin may decrease the rate of overall preterm birth, but investigators have speculated that this is likely due to a decrease in medically indicated preterm birth through its effect on the incidence of preeclampsia and other placental disease. We hypothesized that low-dose aspirin may also have an impact on the mechanism of spontaneous preterm labor. OBJECTIVE: Our objective was to determine whether low-dose aspirin reduces the rate of spontaneous preterm birth in nulliparous women without medical comorbidities. STUDY DESIGN: This is a secondary analysis of a randomized, placebo-controlled trial of low-dose aspirin for the prevention of preeclampsia in healthy, low-risk, nulliparous women. Low-risk women were defined by the absence of hypertension, renal disease, diabetes, other endocrine disorders, seizures, heart disease, or collagen vascular disease. Our study was limited to singleton, nonanomalous gestations. Women were eligible if they had prior pregnancy terminations but not prior spontaneous pregnancy loss <20 weeks. Current pregnancies that resulted in a loss or termination <20 weeks or antepartum stillbirth or had missing follow-up data were excluded. The treatment intervention was 60 mg of aspirin, initiated at 13-25 weeks' gestation or matching placebo. The primary outcome was spontaneous preterm birth <34 weeks' gestation. Secondary outcomes included spontaneous preterm birth <37 weeks and overall preterm birth <37 and <34 weeks. Baseline demographics and primary and secondary outcomes were compared between treatment groups. A logistic regression model was used to adjust for confounders related to spontaneous preterm birth. RESULTS: Of 2543 included women, 1262 (49.6%) received low-dose aspirin and 1281 (50.4%) placebo. Baseline characteristics were similar between groups, except for marital status. The rate of spontaneous preterm birth <34 weeks was 1.03% (n = 13) and 2.34% (n = 30) in the low-dose aspirin and placebo group, respectively (odds ratio, 0.43, 95% confidence interval, 0.26-0.84). Additionally, the rate of spontaneous preterm birth <37 weeks was 6.58% (n = 83) in the low-dose aspirin group and 7.03% (n = 90) in the placebo group (odds ratio, 0.97, 95% confidence interval, 0.71-1.33), and the rate of overall preterm birth <37 weeks was 7.84% (n = 99) in the low-dose aspirin group and 8.2% (n = 105) in the placebo group (odds ratio, 0.97, 95% confidence interval, 0.72-1.31). After adjustment for variables that were clinically relevant or statistically significant, including body mass index, race, tobacco use, marital status, and education level, there was a significant reduction in spontaneous preterm birth <34 weeks in the low-dose aspirin group (adjusted odds ratio, 0.46, 95% confidence interval, 0.23-0.89). The rates of overall preterm birth <34 and <37 weeks and spontaneous preterm birth <37 weeks were similar in women who received low-dose aspirin compared with placebo. CONCLUSION: Low-dose aspirin is associated with a substantial decrease in spontaneous preterm birth <34 weeks in healthy nulliparous women without comorbidities. These findings suggest a new therapeutic option for preterm birth prevention that requires further study.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Andrikopoulou M, Purisch SE, Handal-Orefice R, et al. Low-dose aspirin is associated with reduced spontaneous preterm birth in nulliparous women. Am J Obstet Gynecol. 2018. PMID: 29913174. doi:10.1016/j.ajog.2018.06.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。